“biogen” Archives

in
Entry Author Date Location
Bristol-Myers, BioMotiv Pact Leads to a New Fibrosis-Focused Startup 02/04/20 New York
Bio Roundup: Coronavirus Concerns, Sarepta’s CRL, Eye Drug OK’d & More 01/24/20 National
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More 01/17/20 National
Biogen Adds Another Neuro Drug to Pipeline in Deal With Pfizer 01/13/20 Boston
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More 01/10/20 National
Biogen Teams Up With Startup CAMP4 to Scout for New Neuro Drugs 01/10/20 Boston
Biogen Strikes Alzheimer’s Deal, Paying $45M for Ionis Tau Drug Rights 12/19/19 San Diego
3 Takeaways From the Resurrection of Biogen’s Alzheimer’s Drug 12/06/19 San Diego
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More 12/06/19 National
Biogen Points to Enrollment and Dosing to Explain Alzheimer’s Results 12/05/19 National
As Alzheimer’s Conference Kicks Off, All Eyes Are on Biogen’s Drug 12/05/19 San Diego
Alkermes Eyes Brain Disorders and Beyond With $100M Deal for Rodin 11/18/19 Boston
Roche Challenger to Biogen’s SMA Drug Succeeds in Pivotal Study 11/11/19 National
Bio Roundup: Feds Sue Gilead, Biogen Eyes China, CRISPR’d Kidneys & More 11/08/19 National
AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund 11/06/19 National
Biogen Adds Two More Biosimilars in $100M Deal with Samsung Bioepis 11/06/19 Boston
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More 11/01/19 National
Pinteon Gets $17M to Tackle Tau in Alzheimer’s, Other Brain Diseases 10/31/19 Boston
FDA Halts Novartis Gene Therapy Study Amid Animal Safety Concerns 10/30/19 National
Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More 10/25/19 National
Biogen Reverses Course on Alzheimer’s Drug Analysis, Plans FDA Filing 10/22/19 Boston
Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More 10/11/19 San Francisco
Bio Roundup: PARP Progress, A New Commish, IPO-Palooza & More 10/04/19 National
Biogen’s Ehlers Leaving for Apple Tree, Steps Into Limelight as CEO 10/01/19 New York
Bio Roundup: Pelosi’s Reveal, Alder’s Deal, Biogen’s Fails & More 09/20/19 National
BACEless: Eisai, Biogen Pull Plug on Alzheimer’s Drug in Final Stage 09/13/19 Boston
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More 09/13/19 National
Phil Sharp, CRISPR’ing the Heart & the Duchenne Data Gap on Oct. 17 09/11/19 Boston
Vir Bio Plans IPO to Fund Clinical Trials of Infectious Disease Drugs 09/03/19 San Francisco
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Page 2 of 12 « previous page · next page »